Jesper Kers

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Kidney Transplantation

Polycyclic Aromatic Hydrocarbons

Top Venues

The Journal of pathology

Mass spectrometry reviews

Nature reviews. Nephrology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Talita Rojas Sanches, Antonio Carlos Parra, Peiqi Sun, Mariana Pereira Graner, Lucas Yuji Umesaki Itto, Loes Maria Butter, Nike Claessen, Joris J T H Roelofs, Sandrine Florquin, Mariana Matera Veras, Maria de Fatima Andrade, Paulo Hilário do Nascimento Saldiva, Jesper Kers, Lúcia da Conceição Andrade, Alessandra Tammaro
Air pollution aggravates renal ischaemia-reperfusion-induced acute kidney injury. The Journal of pathology (2024)
Paola Tasca, Bernard M van den Berg, Ton J Rabelink, Gangqi Wang, Bram Heijs, Cees van Kooten, Aiko P J de Vries, Jesper Kers
Application of spatial-omics to the classification of kidney biopsy samples in transplantation. Nature reviews. Nephrology (2024)
Talita Rojas Sanches, Antonio Carlos Parra, Peiqi Sun, Mariana Pereira Graner, Lucas Yuji Umesaki Itto, Loes Maria Butter, Nike Claessen, Joris J T H Roelofs, Sandrine Florquin, Mariana Matera Veras, Maria de Fatima Andrade, Paulo Hilário do Nascimento Saldiva, Jesper Kers, Lúcia da Conceição Andrade, Alessandra Tammaro
Air pollution aggravates renal ischaemia-reperfusion-induced acute kidney injury. The Journal of pathology 263 (4-5) (2024)
Soufian Meziyerh, Teun van Gelder, Jesper Kers, Danny van der Helm, Paul J M van der Boog, Johan W de Fijter, Dirk Jan A R Moes, Aiko P J de Vries
Tacrolimus and Mycophenolic Acid Exposure Are Associated with Biopsy-Proven Acute Rejection: A Study to Provide Evidence for Longer-Term Target Ranges. Clinical pharmacology and therapeutics (2023)
Suzanne Bezstarosti, Soufian Meziyerh, Marlies E J Reinders, Kim Voogt-Bakker, Koen E Groeneweg, Dave L Roelen, Jesper Kers, Johan W de Fijter, Sebastiaan Heidt
HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy. HLA (2023)
Marlies E J Reinders, Koen E Groeneweg, Sanne H Hendriks, Jonna R Bank, Geertje J Dreyer, Aiko P J de Vries, Melissa van Pel, Helene Roelofs, Volkert A L Huurman, Paula Meij, Dirk Jan A R Moes, Willem E Fibbe, Frans H J Claas, Dave L Roelen, Cees van Kooten, Jesper Kers, Sebastiaan Heidt, Ton J Rabelink, Johan W de Fijter
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (9) (2021)
Irena Dapic, Lucia Baljeu-Neuman, Naomi Uwugiaren, Jesper Kers, David R Goodlett, Garry L Corthals
Proteome analysis of tissues by mass spectrometry. Mass spectrometry reviews 38 (4-5) (2019)